+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)



Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)



International Journal of Radiation Oncology*biology*physics 94(1): 5-6




(PDF emailed within 0-6 h: $19.90)

Accession: 064901014

Download citation: RISBibTeXText

DOI: 10.1016/j.ijrobp.2015.10.040


Related references

OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC. RadioTherapy and Oncology 119: S61-S62, 2016

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. Journal of Clinical Oncology 2019: Jco1800622, 2019

Stereotactic Body Radiation Therapy (SBRT) For Centrally Located Primary and Recurrent Non-Small Cell Lung Cancer: Analysis of Toxicity and Local Control. International Journal of Radiation Oncology*biology*physics 93(3): E418-E419, 2015

A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial). Japanese Journal of Clinical Oncology 2017, 2017

Stereotactic Body Radiation Therapy (SBRT) for Primary Non-Small Cell Lung Cancer (NSCLC) and Pulmonary Metastases: Analysis of Outcomes and Predictive Factors for Local Control. International Journal of Radiation Oncology*biology*physics 87(2): S532-S533, 2013

Safety and Efficacy of Second Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-small Cell Lung Cancer (NSCLC) or Lung Metastasis Previously Treated With SBRT. International Journal of Radiation Oncology*biology*physics 84(3): S569-S570, 2012

Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC). Anticancer Research 36(2): 825-828, 2016

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). International Journal of Clinical Oncology 22(5): 849-856, 2017

Changes in Volumes of Stage I Non-small Cell Lung Cancer (NSCLC) During Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology*biology*physics 84(3): S576-S577, 2012

Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). Journal of Clinical Oncology 26(15_suppl): 7529-7529, 2016

A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. International Journal of Radiation Oncology, Biology, Physics 82(1): 435-41.E1, 2012

Safety and Efficacy of Repeat Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-Small Cell Lung Cancer (NSCLC) and Lung Metastasis. International Journal of Radiation Oncology*biology*physics 93(3): E409-E410, 2015

Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances. Journal of Thoracic Disease 10(Suppl 21): S2451-S2464, 2018

Adjuvant Systemic Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT). Journal of Thoracic Oncology 2018, 2018

Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). Acta Oncologica 57(11): 1567-1573, 2018